Abbvie

LUPRON DEPOT

Manufacturer:

Abbvie

Lupron Depot HCPCS:

J1950

HCPCS Code Descriptor:

Injection, leuprolide acetate (for depot suspension), per 3.75 mg

Category:

J Code

Lupron Depot NDCs:

00074-2108-03, 00074-3641-03, 00074-2282-03, 00074-2440-03, 00074-2440-03, 00074-3663-03, 00074-9694-03, 00074-3779-03, 00074-3575-01

Primary Type:

Growth Disorder

Generic/Specialty Status:

Single-Source

Package Type:

Kit

Route of Administration:

Intramuscular

Lupron Depot CPT Codes:

Potential CPT administration codes for Lupron Depot can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Lupron Depot:

LUPRON DEPOT is a Growth Disorder drug manufactured by Abbvie and administered via the Intramuscular route of administration. The J Code: J1950 is aligned to the drug LUPRON DEPOT.

ACCESS PRICING AND MORE BY REGISTERING

J1950 Added Date:

January 1, 1986

J1950 Effective Date:

January 1, 1997

J1950 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Lupron Depot billing and coding information.
Lupron Depot patient assistance information can be found through Abbvie Patient Access Support at the URL: https://www.abbvie.com/content/dam/abbvie-com2/pdfs/pap/lupron-application.pdf
LUPRON DEPOT prescribing information can be found at the link below:
Information regarding LUPRON DEPOT’s side effects can be found at MedlinePlus